NasdaqGS - Delayed Quote USD

CG Oncology, Inc. (CGON)

25.84 -2.66 (-9.33%)
At close: May 13 at 4:00 PM EDT
27.01 +1.17 (+4.53%)
Pre-Market: 8:14 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
539.00
204.00
191.00
10,358.00
Operating Expense
68,736.00
55,653.00
35,437.00
22,964.00
Operating Income
-68,197.00
-55,449.00
-35,246.00
-12,606.00
Net Non Operating Interest Income Expense
11,404.00
6,904.00
-1.00
-451.00
Other Income Expense
-79.00
-62.00
-196.00
218.00
Pretax Income
-56,872.00
-48,607.00
-35,443.00
-12,839.00
Net Income Common Stockholders
-72,329.00
-67,798.00
-43,788.00
-18,383.00
Diluted NI Available to Com Stockholders
-72,329.00
-67,798.00
-43,788.00
-18,383.00
Basic EPS
-1.09
-15.65
-11.71
-0.55
Diluted EPS
-1.09
-15.65
-11.71
-0.55
Basic Average Shares
66,636.25
4,330.93
3,740.89
33,699.98
Diluted Average Shares
66,636.25
4,330.93
3,740.89
33,699.98
Total Operating Income as Reported
-68,197.00
-55,449.00
-35,246.00
-12,606.00
Total Expenses
68,736.00
55,653.00
35,437.00
22,964.00
Net Income from Continuing & Discontinued Operation
-56,872.00
-48,607.00
-35,443.00
-12,839.00
Normalized Income
-56,872.00
-48,607.00
-35,443.00
-12,839.00
Interest Expense
--
--
1.00
451.00
Net Interest Income
11,404.00
6,904.00
-1.00
-451.00
EBIT
-68,197.00
-55,449.00
-35,246.00
-12,388.00
EBITDA
-68,180.00
-55,432.00
-35,231.00
-12,378.00
Reconciled Depreciation
17.00
17.00
15.00
10.00
Net Income from Continuing Operation Net Minority Interest
-56,872.00
-48,607.00
-35,443.00
-12,839.00
Normalized EBITDA
-68,180.00
-55,432.00
-35,231.00
-12,378.00
12/31/2021 - 1/25/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KYTX Kyverna Therapeutics, Inc.
14.63
+4.50%
 
ANRO Alto Neuroscience, Inc.
14.09
+4.45%
 
GPCR Structure Therapeutics Inc.
35.99
+0.47%
 
SLRN Acelyrin, Inc.
4.6900
+0.21%
 
AVBP ArriVent BioPharma, Inc.
17.93
+1.30%
 
CABA Cabaletta Bio, Inc.
11.26
0.00%
 
RYTM Rhythm Pharmaceuticals, Inc.
40.20
+2.71%
 
MGX Metagenomi, Inc.
6.55
0.00%
 
APGE Apogee Therapeutics, Inc.
52.73
-0.92%
 
JANX Janux Therapeutics, Inc.
49.99
+2.19%